Ignite Creation Date:
2025-12-26 @ 2:39 PM
Ignite Modification Date:
2026-03-03 @ 6:16 AM
Study NCT ID:
NCT03215706
Status:
COMPLETED
Last Update Posted:
2025-12-17
First Post:
2017-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-18
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-11
First Submit QC Date:
None
Study First Post Date:
2017-07-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-08-15
Results First Submit QC Date:
None
Results First Post Date:
2020-09-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-02
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED